Menu

John Iversen Explores our Perception of Musical Rhythm

At the Swartz Center for Computational Neuroscience at the University of California, San Diego, the researcher studies the neurobiology of music perception.

Mar 1, 2017
Vijay Shankar Balakrishnan

© FRANK ROGOZIENSKIWhen he was a toddler, John Iversen made his first drum set out of pots and pans. But he soon joined his family of percussionists to play real drums and, as a teenager, founded his own rock band. Iversen became curious about the impact of music on humans and animals while studying physics as a Harvard University undergrad.

“You do find many people studying [the] neuroscience of music are musicians, and I’m no different,” he says.

Auditory physiologist Nelson Kiang in the Eaton-Peabody Laboratory at Harvard/MIT helped Iversen chart his career path. In 1992, Iversen started his PhD research in the lab of Harvard auditory researcher Christian Brown. But he interacted a lot with Kiang, who studied how the ear transmits auditory signals to the brain and the neural processing that follows. “Most graduate students in science nowadays do research really organized and thought through by their supervisors, but John actually researched [his own idea],” Kiang says. “That was an early indication that he would be a creative scientist, rather than someone who just goes through the motions.”

In 2001, Iversen’s study of music and the brain took off in earnest after his grad school classmate Ani Patel invited Iversen to join him at the Neurosciences Institute in San Diego to do postdoctoral research in a budding program on the subject.

Working together for about 12 years, the collaborators published several noteworthy papers. One was inspired by a YouTube video that featured a sulphur-crested cockatoo named Snowball rhythmically dancing to musical beats.1  Patel and Iversen sent slowed-down and sped-up versions of the song from the clip to Snowball’s owner, who recorded videos of the bird dancing to those versions and returned them to the researchers, who tested whether the bird’s dancing tempo changed.

“John brought a lot of wonderful insight to that project,” recalls Patel, who is now at Tufts University. “This brought a lot of interest in the issue of how other animals experience human music .?.?. and how to understand the evolution of our perception of music,” Patel says.

Iversen, now at the University of California, San Diego, studies the neural mechanisms of rhythm perception—trying to pinpoint which brain circuits enable us to dance and detect rhythm in music and speech. He demonstrated the active role of the brain in shaping how a listener perceives a rhythm, a finding that formed the basis of the action simulation for auditory prediction (ASAP) hypothesis.2,3 According to this hypothesis, listening to rhythms is not solely auditory, but is fundamentally shaped by the brain’s motor regions, which predict incoming beats. This suggests that the complex coordination between auditory and motor planning regions involves a neural circuit that was strengthened as humans evolved vocal learning and musical rhythm perception.

With Ramesh Balasubramaniam, a neuroscientist at the University of California, Merced, Iversen is now investigating the ASAP hypothesis in humans by measuring brain function with electroencephalography and directly testing whether auditory perception is disrupted after temporarily disabling motor regions using transcranial magnetic simulation.

“[Iversen] is one of the most original thinkers in the world of music and auditory neuroscience,” Balasubramaniam says, “and is one of the few people I know that can bridge a wide gap between evolutionary biology, cognitive psychology, and the brain sciences.” 

REFERENCES

  1. A.D. Patel et al., “Experimental evidence for synchronization to a musical beat in a nonhuman animal,” Curr Biol, 19:827-30, 2009. (Cited by 360)
  2. J.R. Iversen et al., “Top-down control of rhythm perception modulates early auditory responses,” Ann N Y Acad Sci, 1169:58-73, 2009. (Cited by 153)
  3. A.D. Patel, J.R. Iversen, “The evolutionary neuroscience of musical beat perception: The Action Simulation for Auditory Prediction (ASAP) hypothesis,” Front Syst Neurosci, 8:57, 2014. (Cited by 82)

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.